Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Liquid biopsy: Potential and challenges.

Literature DB >> 26875532

Liquid biopsy: Potential and challenges.

Klaus Pantel¹, Catherine Alix-Panabières².

Abstract

Mesh：

Substances：

Year: 2016 PMID： 26875532 PMCID： PMC5528972 DOI： 10.1016/j.molonc.2016.01.009

Source DB: PubMed Journal: Mol Oncol ISSN： 1574-7891 Impact factor: 6.603

× No keyword cloud information.

29 in total

1. Liquid biopsy: Potential and challenges.

Authors: Klaus Pantel; Catherine Alix-Panabières
Journal: Mol Oncol Date: 2016-02-01 Impact factor: 6.603

Review 2. Challenges in circulating tumour cell research.

Authors: Catherine Alix-Panabières; Klaus Pantel
Journal: Nat Rev Cancer Date: 2014-07-31 Impact factor: 60.716

Review 3. Controversies in clinical cancer dormancy.

Authors: Jonathan W Uhr; Klaus Pantel
Journal: Proc Natl Acad Sci U S A Date: 2011-07-11 Impact factor: 11.205

4. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

Authors: Takehiko Yokobori; Hisae Iinuma; Teppei Shimamura; Seiya Imoto; Keishi Sugimachi; Hideshi Ishii; Masaaki Iwatsuki; Daisuke Ota; Masahisa Ohkuma; Takeshi Iwaya; Naohiro Nishida; Ryunosuke Kogo; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hiroyuki Toh; Tetsuya Sato; Graham F Barnard; Takeo Fukagawa; Seiichiro Yamamoto; Hayao Nakanishi; Shin Sasaki; Satoru Miyano; Toshiaki Watanabe; Hiroyuki Kuwano; Koshi Mimori; Klaus Pantel; Masaki Mori
Journal: Cancer Res Date: 2013-02-01 Impact factor: 12.701

5. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.

Authors: Irène Baccelli; Andreas Schneeweiss; Sabine Riethdorf; Albrecht Stenzinger; Anja Schillert; Vanessa Vogel; Corinna Klein; Massimo Saini; Tobias Bäuerle; Markus Wallwiener; Tim Holland-Letz; Thomas Höfner; Martin Sprick; Martina Scharpff; Frederik Marmé; Hans Peter Sinn; Klaus Pantel; Wilko Weichert; Andreas Trumpp
Journal: Nat Biotechnol Date: 2013-04-21 Impact factor: 54.908

6. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

Authors: Cassandra L Hodgkinson; Christopher J Morrow; Yaoyong Li; Robert L Metcalf; Dominic G Rothwell; Francesca Trapani; Radoslaw Polanski; Deborah J Burt; Kathryn L Simpson; Karen Morris; Stuart D Pepper; Daisuke Nonaka; Alastair Greystoke; Paul Kelly; Becky Bola; Matthew G Krebs; Jenny Antonello; Mahmood Ayub; Suzanne Faulkner; Lynsey Priest; Louise Carter; Catriona Tate; Crispin J Miller; Fiona Blackhall; Ged Brady; Caroline Dive
Journal: Nat Med Date: 2014-06-01 Impact factor: 53.440

7. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors: Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal: Nature Date: 2012-06-28 Impact factor: 49.962

8. Hematogenous dissemination of glioblastoma multiforme.

Authors: Carolin Müller; Johannes Holtschmidt; Martina Auer; Ellen Heitzer; Katrin Lamszus; Alexander Schulte; Jakob Matschke; Sabine Langer-Freitag; Christin Gasch; Malgorzata Stoupiec; Oliver Mauermann; Sven Peine; Markus Glatzel; Michael R Speicher; Jochen B Geigl; Manfred Westphal; Klaus Pantel; Sabine Riethdorf
Journal: Sci Transl Med Date: 2014-07-30 Impact factor: 17.956

9. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Authors: Aaron M Newman; Scott V Bratman; Jacqueline To; Jacob F Wynne; Neville C W Eclov; Leslie A Modlin; Chih Long Liu; Joel W Neal; Heather A Wakelee; Robert E Merritt; Joseph B Shrager; Billy W Loo; Ash A Alizadeh; Maximilian Diehn
Journal: Nat Med Date: 2014-04-06 Impact factor: 53.440

10. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.

Authors: Myron G Best; Nik Sol; Irsan Kooi; Jihane Tannous; Bart A Westerman; François Rustenburg; Pepijn Schellen; Heleen Verschueren; Edward Post; Jan Koster; Bauke Ylstra; Najim Ameziane; Josephine Dorsman; Egbert F Smit; Henk M Verheul; David P Noske; Jaap C Reijneveld; R Jonas A Nilsson; Bakhos A Tannous; Pieter Wesseling; Thomas Wurdinger
Journal: Cancer Cell Date: 2015-10-29 Impact factor: 31.743

35 in total

1. Liquid biopsy: Potential and challenges.

Authors: Klaus Pantel; Catherine Alix-Panabières
Journal: Mol Oncol Date: 2016-02-01 Impact factor: 6.603

2. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).

Authors: Raffaele Palmirotta; Domenica Lovero; Erica Silvestris; Claudia Felici; Davide Quaresmini; Paola Cafforio; Franco Silvestris
Journal: Cancer Genomics Proteomics Date: 2017 May-Jun Impact factor: 4.069

3. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors: Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal: PLoS One Date: 2017-01-06 Impact factor: 3.240

Review 4. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.

Authors: David Pérez-Callejo; Atocha Romero; Mariano Provencio; María Torrente
Journal: Transl Lung Cancer Res Date: 2016-10

5. Completing the Translation.

Authors: Robert T McCormack; Daniel F Hayes
Journal: Oncologist Date: 2019-10-16

6. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy.

Authors: Lisa König; Sabine Kasimir-Bauer; Ann-Kathrin Bittner; Oliver Hoffmann; Bettina Wagner; Luis Felipe Santos Manvailer; Rainer Kimmig; Peter A Horn; Vera Rebmann
Journal: Oncoimmunology Date: 2017-09-27 Impact factor: 8.110

Review 10. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.

Authors: Michael Rink; Heidi Schwarzenbach; Sabine Riethdorf; Armin Soave
Journal: World J Urol Date: 2018-10-26 Impact factor: 4.226

Liquid biopsy: Potential and challenges.

1. Liquid biopsy: Potential and challenges.

Review 2. Challenges in circulating tumour cell research.

Review 3. Controversies in clinical cancer dormancy.

4. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

5. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.

6. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer.

7. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

8. Hematogenous dissemination of glioblastoma multiforme.

9. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

10. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.

1. Liquid biopsy: Potential and challenges.

2. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).

3. Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Review 4. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.

5. Completing the Translation.

6. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy.

7. Completing the Translation.

Review 8. Pathologists and liquid biopsies: to be or not to be?

Review 9. Application of liquid biopsy in precision medicine: opportunities and challenges.

Review 10. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.